Mckenzie Taylor Donaldson, MED | |
1130 1st St N Ste 200, Alabaster, AL 35007-8771 | |
(205) 624-2422 | |
(205) 624-3091 |
Full Name | Mckenzie Taylor Donaldson |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 1130 1st St N Ste 200, Alabaster, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255954038 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
101Y00000X | Counselor | (* (Not Available)) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Mckenzie Taylor Donaldson, MED 1130 1st St N Ste 200, Alabaster, AL 35007-8771 Ph: (205) 624-2422 | Mckenzie Taylor Donaldson, MED 1130 1st St N Ste 200, Alabaster, AL 35007-8771 Ph: (205) 624-2422 |
News Archive
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
The third night of the Democratic National Convention was all about one thing: Sen. Kamala Harris of California becoming the first Black and Indian American woman to accept a major political party's vice presidential nomination.
With advances in medicine helping more people to live longer lives, the number of people over the age of 60 is expected to double by 2050 and will require radical societal change, according to a new report released by the WHO for the International Day of Older Persons (1 October).
Researchers identified an accurate method that may detect whether obese individuals have a low, intermediate or high risk of coronary artery disease, the leading cause of death in the United States, notes a report in the August issue of the Journal of Nuclear Medicine.
Research released today demonstrates how new scientific knowledge is driving innovative treatments for spinal cord injuries. Spinal cord damage is debilitating and life-altering, limiting or preventing movement and feeling for millions worldwide, and leading to chronic health conditions and pain.
› Verified 5 days ago
Jennifer Renee O'dowd, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1216 1st St N, Alabaster, AL 35007 Phone: 205-777-7706 | |
Karen W Wheat, ALC Counselor Medicare: Not Enrolled in Medicare Practice Location: 750 Highway 31 S, Alabaster, AL 35007 Phone: 205-216-0200 | |
Deana Cherie Hickey, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1130 1st St N Ste 200, Alabaster, AL 35007 Phone: 205-624-2422 Fax: 844-763-3291 | |
Mr. Joshua Peter Shoemake, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 122 1st St S, Alabaster, AL 35007 Phone: 205-624-2422 | |
Melba Davis Holloway, EDS Counselor Medicare: Not Enrolled in Medicare Practice Location: 224 1st St N Ste 250, Alabaster, AL 35007 Phone: 205-624-2422 Fax: 205-624-3091 | |
Nanci Neighbors Scarpulla, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 6919 Highway 119 Ste 100b, Alabaster, AL 35007 Phone: 205-790-8558 | |
Melanie Jill Dean, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 101 Aviators View Dr, Alabaster, AL 35007 Phone: 205-419-3590 Fax: 205-621-4529 |